|
DHX33 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.446400E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.801600E-01 |
| Normal-vs-Stage2 |
9.198400E-02 |
| Normal-vs-Stage3 |
2.669900E-02 |
| Normal-vs-Stage4 |
9.335400E-03 |
| Stage1-vs-Stage2 |
9.151900E-02 |
| Stage1-vs-Stage3 |
1.676490E-02 |
| Stage1-vs-Stage4 |
5.023400E-03 |
| Stage2-vs-Stage3 |
8.921000E-01 |
| Stage2-vs-Stage4 |
5.110800E-01 |
| Stage3-vs-Stage4 |
5.395000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.034760E-01 |
| Normal-vs-AfricanAmerican |
6.635500E-02 |
| Normal-vs-Asian |
2.001800E-01 |
| Caucasian-vs-AfricanAmerican |
2.226600E-01 |
| Caucasian-vs-Asian |
6.940300E-02 |
| AfricanAmerican-vs-Asian |
5.820000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.125700E-02 |
| Normal-vs-Female |
4.850200E-01 |
| Male-vs-Female |
2.159000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.908200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.145400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.416100E-02 |
| Normal-vs-Age(81-100Yrs) |
7.646200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.603000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.325000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.606200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.855190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.565570E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.110600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.703900E-02 |
| Normal-vs-Grade 2 |
8.429200E-01 |
| Normal-vs-Grade 3 |
4.571900E-02 |
| Normal-vs-Grade 4 |
3.723600E-03 |
| Grade 1-vs-Grade 2 |
1.837190E-01 |
| Grade 1-vs-Grade 3 |
5.416200E-02 |
| Grade 1-vs-Grade 4 |
1.232090E-02 |
| Grade 2-vs-Grade 3 |
5.976000E-02 |
| Grade 2-vs-Grade 4 |
3.403000E-03 |
| Grade 3-vs-Grade 4 |
1.311750E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.118800E-01 |
| Normal-vs-ccB subtype |
1.133570E-01 |
| ccA subtype-vs-ccB subtype |
1.696340E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.486600E-01 |
| Normal-vs-N1 |
8.808600E-01 |
| N0-vs-N1 |
8.184600E-01 |
|
|
